Shenzhen Institute of Geriatrics
The Shenzhen Institute of Geriatrics (hereinafter referred to as the Institute) is led by Professor Zhengzhi Wu, a foreign academician of the National Academy of Engineering of Ukraine, Scientist of the Year (2016) in China, and a national expert with outstanding contributions. The Institute currently houses six national, provincial, and municipal key laboratories, including the National Proteomics Tertiary Laboratory, National Key Traditional Chinese Medicine Research Laboratory, National TCM Molecular Immunology Secondary Laboratory, and Shenzhen Nanomedicine Engineering Laboratory, as well as the Geriatrics Research Center led by Academician Keji Chen of the Chinese Academy of Sciences and a postdoctoral innovation practice base.
The Institute has undertaken more than 150 research projects, including national 973, 863, national science and technology projects, and projects funded by the National Natural Science Foundation. It has received 26 science and technology achievement awards, such as the first prize of the National Education Commission's Science and Technology Progress (Natural Science) Award, the first prize of the Chinese Society of Integrative Medicine Science and Technology Award, and the second prize of the Guangdong Province Science and Technology Award. These awards make it the unit with the most science and technology achievement awards in Shenzhen's biomedical field, accounting for two-thirds of the provincial and ministerial-level awards in the Shenzhen Health and Wellness Committee system. The Institute has published over 500 professional academic papers in core journals at home and abroad, including over 100 papers in JCR Q1 and Q2 journals. It has authored and published 48 university textbooks and professional academic works, such as "Geriatric Neurology" and "TCM Dietetics." The Institute has applied for and obtained 259 domestic and international invention patents and has trained over 60 high-level professional and technical personnel, including postdoctoral fellows, doctoral candidates, and master's students.
The Institute's three main research directions are as follows:
Development of Original Innovative Drugs and Precision Health Products (Homology of Medicine and Food):
Includes the total synthesis of natural active peptides and small molecule high-activity natural products, their raw materials and intermediates, the development of original innovative drugs such as biological peptide drugs, small molecule chemical drugs, and modern traditional Chinese medicine, and innovation in nano-targeted drug delivery systems.
Early Molecular Diagnosis and Precision Intervention (Precision Medicine):
Involves the innovative development of non-invasive molecular diagnostic techniques using multi-omics, precision intervention techniques in gene therapy and immunotherapy, and gene sequencing and reprogramming technologies.
Intelligent Diagnosis and Treatment Robots for Integrated Chinese and Western Medicine:
Encompasses the innovation and development of high-end nano-molecular robots and biosensors, ultrasound diagnostic robots, minimally invasive surgical robots, intelligent rehabilitation series bionic robots, and intelligent diagnosis and treatment robots for traditional Chinese medicine, including tongue diagnosis, visual diagnosis, massage, and acupuncture robots.
The Institute has established advanced technical platforms with distinctive advantages in biomedicine research and development, leveraging the existing advanced technology and talent team advantages of the Institute of Geriatrics to achieve complementary advantages in integrating production, education, and research resources.
